tradingkey.logo
tradingkey.logo
Search

Bristol-Myers Squibb Co

BMY
Add to Watchlist
59.365USD
+1.785+3.10%
Close 07/13, 16:00ETQuotes delayed by 15 min
121.22BMarket Cap
16.62P/E TTM

Bristol-Myers Squibb Co Earnings Date

Period
FY2025 Earnings Date
Revenue(YoY)
48.19B
-0.22%
EPS(YoY)
3.47
178.56%
Analyst Rating
HOLD
2026-07-13

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its total revenue reached 48.19B, with a year-on-year change of -0.22.

What are the current assets of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its current assets were 29.39B, with a year-on-year change of -1.31.

What are the total assets of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its total assets of Bristol-Myers Squibb Co were 90.04B, with a year-on-year change of -2.77.

What are the total liabilities of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its total liabilities of Bristol-Myers Squibb Co were 71.53B, with a year-on-year change of -6.14.

What is the total equity of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its total equity of Bristol-Myers Squibb Co was 18.51B, with a year-on-year change of 12.92.

What is the net investment of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its net investment of Bristol-Myers Squibb Co was -4.13B, with a year-on-year change of 80.65.

What is the net financing of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its net financing of Bristol-Myers Squibb Co was -10.35B, with a year-on-year change of -301.83.

What is the Earnings Per Share (EPS) of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its Earnings Per Share (EPS) was 3.47, with a year-on-year change of 178.56.

What is the net margin of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its net profit margin was 14.64, with a year-on-year change of 179.15.

What is the gross margin of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its gross margin was 65.74, with a year-on-year change of 15.55.

What is the debt-to-asset ratio of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its debt-to-asset ratio was 50.10, with a year-on-year change of -6.55.

What is the Return on Equity (ROE) of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its Return on Equity (ROE) was 40.53, with a year-on-year change of 203.65.

What is the Return on Assets (ROA) of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its Return on Assets (ROA) was 7.73, with a year-on-year change of 181.19.

What is the operating profit of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its operating profit was 17.26B, with a year-on-year change of 49.54.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.